
AGC Biologics Email Format
Pharmaceutical Manufacturing
・
1,001-2,500 employees
・
Bothell, WA, USA
AGC Biologics is a global biopharmaceutical contract development and manufacturing organization providing therapeutic protein, mRNA, viral vector, and cell therapy production services.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
firstinitiallast@agcbio.com
Company Overview
Industry
Pharmaceutical Manufacturing
Headquarters
Bothell, WA, USA
Revenue
$1B-$2.5B
FUNDING Stage
Public
Website
Key Executives
Alberto Santagostino (Chief Executive Officer and President), Carrie Mygatt (Executive Vice President, Finance), Kasper Møller (Chief Technical Officer and Executive Vice President, Europe & Japan Regions)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of AGC Biologics?
AGC Biologics uses the firstinitiallast format, so Jane Smith would be jsmith@agcbio.com.
What modalities does AGC Biologics support across its global CDMO network?
AGC Biologics provides contract development and manufacturing services for mammalian and microbial biologics, plasmid DNA, mRNA, viral vectors, and cell therapies, spanning facilities in the U.S., Europe, and Asia.
Where are the AGC Biologics manufacturing sites located around the world?
AGC Biologics operates cGMP-compliant facilities in Seattle, Copenhagen, Heidelberg, Milan, Chiba, and Yokohama, giving it a tri-regional footprint across North America, Europe, and Asia.
How can I find and verify contact information for AGC Biologics business development representatives?
You can use Clay to enrich and verify contact details for AGC Biologics business development or scientific affairs contacts, which is especially useful when building outreach lists for CDMO partnership conversations.
What is the AGC Biologics Cell and Gene Technologies Division, and what proprietary platforms does it offer?
The AGC Biologics Cell and Gene Technologies Division, centered at its Milan Cell and Gene Center of Excellence, offers end-to-end services for CAR-T, viral vectors, and cell therapies, including the proprietary ProntoLVV lentiviral and BravoAAV adeno-associated vector platforms.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating


